Literature DB >> 10221538

Predominance of human immunodeficiency virus type 2 subtype B in Abidjan, Ivory Coast.

D Pieniazek1, D Ellenberger, L M Janini, A C Ramos, J Nkengasong, M Sassan-Morokro, D J Hu, I M Coulibally, E Ekpini, C Bandea, A Tanuri, A E Greenberg, S Z Wiktor, M A Rayfield.   

Abstract

We analyzed the genetic variability and phylogenetic relationships among 28 HIV-2 strains collected from patients enrolled in an HIV epidemiologic study in Abidjan, Ivory Coast, during 1995-1996. Although both subtype A (n = 8; 29%) and subtype B (n = 20; 71%) were present in this sampling, the majority of infections were caused by subtype B viruses. These findings contrasted with the reported predominance of HIV-2 subtype A in other African countries. The broad genetic diversity identified among protease gene sequences for HIV-2 subtype A (6%; range 3-15%) and subtype B (7%; range, 2-12%), and their presence in Abidjan during the 1980s, document a long coexistence of two viral subtypes in Ivory Coast. Our data indicate that viruses of subtypes A and B have contributed to the HIV-2 epidemic in Ivory Coast.

Entities:  

Mesh:

Year:  1999        PMID: 10221538     DOI: 10.1089/088922299311132

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  19 in total

1.  Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.

Authors:  Charlotte Charpentier; Bénédicte Roquebert; Olivier Delelis; Lucile Larrouy; Sophie Matheron; Roland Tubiana; Marina Karmochkine; Xavier Duval; Geneviève Chêne; Alexandre Storto; Gilles Collin; Antoine Bénard; Florence Damond; Jean-François Mouscadet; Françoise Brun-Vézinet; Diane Descamps
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors.

Authors:  Michel Ntemgwa; Bluma G Brenner; Maureen Oliveira; Daniela Moisi; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

3.  Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.

Authors:  F Damond; F Brun-Vezinet; S Matheron; G Peytavin; P Campa; S Pueyo; F Mammano; S Lastere; I Farfara; F Simon; G Chene; D Descamps
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 4.  Antiretroviral drug resistance in human immunodeficiency virus type 2.

Authors:  Michel L Ntemgwa; Thomas d'Aquin Toni; Bluma G Brenner; Ricardo J Camacho; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

5.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

6.  V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.

Authors:  J C Plantier; F Damond; S Souquières; F Brun-Vézinet; F Simon; F Barin
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Simian immunodeficiency virus infection in free-ranging sooty mangabeys (Cercocebus atys atys) from the Taï Forest, Côte d'Ivoire: implications for the origin of epidemic human immunodeficiency virus type 2.

Authors:  Mario L Santiago; Friederike Range; Brandon F Keele; Yingying Li; Elizabeth Bailes; Frederic Bibollet-Ruche; Cecile Fruteau; Ronald Noë; Martine Peeters; John F Y Brookfield; George M Shaw; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Genotypic resistance profiles of HIV-2-treated patients in West Africa.

Authors:  Charlotte Charpentier; Serge Eholié; Xavier Anglaret; Mélanie Bertine; Christine Rouzioux; Véronique Avettand-Fenoël; Eugène Messou; Albert Minga; Florence Damond; Jean-Christophe Plantier; François Dabis; Gilles Peytavin; Françoise Brun-Vézinet; Didier K Ekouevi
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

9.  Detection of simian immunodeficiency virus in diverse species and of human immunodeficiency virus Type 2 by using consensus primers within the pol region.

Authors:  Silvina Masciotra; Chunfu Yang; Danuta Pieniazek; Chanda Thomas; Sherry M Owen; Harold M McClure; Renu B Lal
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Conservation of Nef function across highly diverse lineages of SIVsmm.

Authors:  Jan Schmökel; Hui Li; Elizabeth Bailes; Michael Schindler; Guido Silvestri; Beatrice H Hahn; Cristian Apetrei; Frank Kirchhoff
Journal:  Retrovirology       Date:  2009-04-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.